Significant Genes Associated with Mortality and Disease Progression in Grade II and III Glioma

Overview

Journal Biomedicines

Specialty Biomedical Engineering

Date 2024 Apr 27

PMID 38672212

Authors

Bo Mi Choi

Jin Hwan Cheong

Je Il Ryu

Yu Deok Won

Kyueng-Whan Min

Myung-Hoon Han

Affiliations

Soon will be listed here.

Abstract

Background: The Wnt/β-catenin pathway plays a critical role in the tumorigenesis and maintenance of glioma stem cells. This study aimed to evaluate significant genes associated with the Wnt/β-catenin pathway involved in mortality and disease progression in patients with grade II and III glioma, using the Cancer Genome Atlas (TCGA) database.

Methods: We obtained clinicopathological information and mRNA expression data from 515 patients with grade II and III gliomas from the TCGA database. We performed a multivariate Cox regression analysis to identify genes independently associated with glioma prognosis.

Results: The analysis of 34 genes involved in Wnt/β-catenin signaling demonstrated that four genes (CER1, FRAT1, FSTL1, and RPSA) related to the Wnt/β-catenin pathway were significantly associated with mortality and disease progression in patients with grade II and III glioma. We also identified additional genes related to the four significant genes of the Wnt/β-catenin pathway mentioned above. The higher expression of BMP2, RPL18A, RPL19, and RPS12 is associated with better outcomes in patients with glioma.

Conclusions: Using a large-scale open database, we identified significant genes related to the Wnt/β-catenin signaling pathway associated with mortality and disease progression in patients with grade II and III gliomas.

References

Perekatt A, Shah P, Cheung S, Jariwala N, Wu A, Gandhi V . SMAD4 Suppresses WNT-Driven Dedifferentiation and Oncogenesis in the Differentiated Gut Epithelium. Cancer Res. 2018; 78(17):4878-4890. PMC: 6125228. DOI: 10.1158/0008-5472.CAN-18-0043. View

Zhang Y, Wang Y, Zheng G, Liu Y, Li J, Huang H . Follistatin-like 1 (FSTL1) interacts with Wnt ligands and Frizzled receptors to enhance Wnt/β-catenin signaling in obstructed kidneys in vivo. J Biol Chem. 2022; 298(7):102010. PMC: 9234244. DOI: 10.1016/j.jbc.2022.102010. View

Prakash S, Borreguero L, Sylva M, Flores Ruiz L, Rezai F, Gunst Q . Deletion of Fstl1 (Follistatin-Like 1) From the Endocardial/Endothelial Lineage Causes Mitral Valve Disease. Arterioscler Thromb Vasc Biol. 2017; 37(9):e116-e130. DOI: 10.1161/ATVBAHA.117.309089. View

Doncheva N, Morris J, Gorodkin J, Jensen L . Cytoscape StringApp: Network Analysis and Visualization of Proteomics Data. J Proteome Res. 2018; 18(2):623-632. PMC: 6800166. DOI: 10.1021/acs.jproteome.8b00702. View

Guo G, Mao X, Wang P, Liu B, Zhang X, Jiang X . The expression profile of FRAT1 in human gliomas. Brain Res. 2010; 1320:152-8. DOI: 10.1016/j.brainres.2010.01.037. View

Lau M, Ng K, Wong T, Tong M, Lee T, Ming X . FSTL1 Promotes Metastasis and Chemoresistance in Esophageal Squamous Cell Carcinoma through NFκB-BMP Signaling Cross-talk. Cancer Res. 2017; 77(21):5886-5899. DOI: 10.1158/0008-5472.CAN-17-1411. View

Krishnamurthy N, Kurzrock R . Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors. Cancer Treat Rev. 2017; 62:50-60. PMC: 5745276. DOI: 10.1016/j.ctrv.2017.11.002. View

Miranda A, Hamilton P, Zhang A, Pattnaik S, Becht E, Mezheyeuski A . Cancer stemness, intratumoral heterogeneity, and immune response across cancers. Proc Natl Acad Sci U S A. 2019; 116(18):9020-9029. PMC: 6500180. DOI: 10.1073/pnas.1818210116. View

Chi L, Saarela U, Railo A, Prunskaite-Hyyrylainen R, Skovorodkin I, Anthony S . A secreted BMP antagonist, Cer1, fine tunes the spatial organization of the ureteric bud tree during mouse kidney development. PLoS One. 2011; 6(11):e27676. PMC: 3219680. DOI: 10.1371/journal.pone.0027676. View

10.

Xu B . Prediction and analysis of hub genes between glioblastoma and low-grade glioma using bioinformatics analysis. Medicine (Baltimore). 2021; 100(3):e23513. PMC: 7837950. DOI: 10.1097/MD.0000000000023513. View

11.

Zakharova G, Efimov V, Raevskiy M, Rumiantsev P, Gudkov A, Belogurova-Ovchinnikova O . Reclassification of TCGA Diffuse Glioma Profiles Linked to Transcriptomic, Epigenetic, Genomic and Clinical Data, According to the 2021 WHO CNS Tumor Classification. Int J Mol Sci. 2023; 24(1). PMC: 9820617. DOI: 10.3390/ijms24010157. View

12.

Liu Y, Deisenroth C, Zhang Y . RP-MDM2-p53 Pathway: Linking Ribosomal Biogenesis and Tumor Surveillance. Trends Cancer. 2017; 2(4):191-204. PMC: 5531060. DOI: 10.1016/j.trecan.2016.03.002. View

13.

Panda P, Naik P, Praharaj P, Meher B, Gupta P, Verma R . Abrus agglutinin stimulates BMP-2-dependent differentiation through autophagic degradation of β-catenin in colon cancer stem cells. Mol Carcinog. 2018; 57(5):664-677. DOI: 10.1002/mc.22791. View

14.

Liu C, Tu Y, Sun X, Jiang J, Jin X, Bo X . Wnt/beta-Catenin pathway in human glioma: expression pattern and clinical/prognostic correlations. Clin Exp Med. 2010; 11(2):105-12. DOI: 10.1007/s10238-010-0110-9. View

15.

Wen X, Miyake S, Akiyama Y, Yuasa Y . BMP-2 modulates the proliferation and differentiation of normal and cancerous gastric cells. Biochem Biophys Res Commun. 2004; 316(1):100-6. DOI: 10.1016/j.bbrc.2004.02.016. View

16.

van Amerongen R, Nawijn M, Franca-Koh J, Zevenhoven J, van der Gulden H, Jonkers J . Frat is dispensable for canonical Wnt signaling in mammals. Genes Dev. 2005; 19(4):425-30. PMC: 548942. DOI: 10.1101/gad.326705. View

17.

Bindea G, Mlecnik B, Hackl H, Charoentong P, Tosolini M, Kirilovsky A . ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics. 2009; 25(8):1091-3. PMC: 2666812. DOI: 10.1093/bioinformatics/btp101. View

18.

Jo J, van den Bent M, Nabors B, Wen P, Schiff D . Surveillance imaging frequency in adult patients with lower-grade (WHO Grade 2 and 3) gliomas. Neuro Oncol. 2022; 24(7):1035-1047. PMC: 9248400. DOI: 10.1093/neuonc/noac031. View

19.

Deisenroth C, Franklin D, Zhang Y . The Evolution of the Ribosomal Protein-MDM2-p53 Pathway. Cold Spring Harb Perspect Med. 2016; 6(12). PMC: 5131753. DOI: 10.1101/cshperspect.a026138. View

20.

Han M, Min K, Noh Y, Kim J, Cheong J, Ryu J . High DKK3 expression related to immunosuppression was associated with poor prognosis in glioblastoma: machine learning approach. Cancer Immunol Immunother. 2022; 71(12):3013-3027. PMC: 9588473. DOI: 10.1007/s00262-022-03222-4. View